Addus HomeCare August 2018 Common Stock Offering

We represented Addus HomeCare Corporation (Nasdaq: ADUS) in its public offering of 2,100,000 shares of common stock for net proceeds of $59 million. Jefferies LLC, Raymond James & Associates, Inc. and RBC Capital Markets, LLC acted as joint book-runners for the offering, while Robert W. Baird & Co. Inc., Oppenheimer & Co. Inc. and Stephens Inc. acted as co-managers.

Addus HomeCare is one of the nation’s largest and fastest growing providers of personal home care and support services. As of August 2018, Addus provided home care services to approximately 39,000 consumers through 157 locations across 25 states.

You Also May Be Interested In:

  • We represented ALS Education, Inc., an education dropout prevention and recovery program, in the sale of its charter school management...
    Client Type: Private Company
  • Representation of Parthenon Capital, a growth-oriented private equity firm, as healthcare regulatory counsel in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers

    We served as healthcare regulatory counsel to Parthenon Capital, a growth-oriented private equity firm, in its investment in RxSense, a...
    Client Type: Private Company
  • Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management.  Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.

    We served as lead legal counsel to POINT Biopharma Inc., a late stage biopharmaceutical company dedicated to bringing the many...
    Client Type: Private Company